Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Paul Ausick | Oct 13, 2016 at 4:04 PM EDT

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in…

Jon C. Ogg | Oct 13, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Charles Schwab, Merck, Nokia, Viacom, Waste Management, Windstream and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Charles Schwab, Merck, Nokia, Viacom, Waste Management and…

Chris Lange | Oct 12, 2016 at 7:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Paul Ausick | Oct 11, 2016 at 4:04 PM EDT

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in…

Paul Ausick | Oct 10, 2016 at 4:04 PM EDT

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in…

Chris Lange | Oct 10, 2016 at 11:25 AM EDT

Monday’s 3 Major Biopharma Movers

On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.

Paul Ausick | Oct 3, 2016 at 4:04 PM EDT

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in…

Paul Ausick | Sep 28, 2016 at 4:04 PM EDT

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

September 28, 2016: Here are four stocks trading with relatively heavy volume among 33 equities making new 52-week lows in…

Chris Lange | Sep 27, 2016 at 7:40 AM EDT

Major Pharma Continues to See Rising Tide in Short Interest

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Sep 12, 2016 at 4:04 PM EDT

Kroger, Whole Foods in Monday’s 52-Week Low Club

September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in…

Paul Ausick | Sep 2, 2016 at 4:04 PM EDT

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 21 22 23 24 25 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Charles Schwab, Merck, Nokia, Viacom, Waste Management, Windstream and More

Major Pharma Short Sellers Grow More Selective

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

Monday’s 3 Major Biopharma Movers

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Kroger, Whole Foods in Monday’s 52-Week Low Club

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Charles Schwab, Merck, Nokia, Viacom, Waste Management, Windstream and More

Major Pharma Short Sellers Grow More Selective

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

Monday’s 3 Major Biopharma Movers

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Kroger, Whole Foods in Monday’s 52-Week Low Club

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It